Flumist News

on Sep 12, 2017 in news



In the U.S. the ACIP has not recommended the intranasal influenza vaccine, LAIV Flumist for the second season in a row.   This was unfortunate news for patients averse to injections.  Although this information was announced by the CDC back in June, what is of interest currently is the fact Flumist performed well in UK, Canada and Finland.  Experts are analyzing why there’s a discrepancy.  Read more